Symposium discusses measures to better manage asthma in Vietnam

Experts emphasised that asthma management and prevention still faces many challenges. Asthma is also an underlying condition that weakens the body's immune system and creates favourable conditions for viruses to attack, including influenza and the Varicella Zoster Virus, which causes shingles.

A doctor examines a patient with asthma at the Ha Tinh Lung Hospital. (Photo courtesy of the hospital)
A doctor examines a patient with asthma at the Ha Tinh Lung Hospital. (Photo courtesy of the hospital)

Hanoi (VNS/VNA) - Health experts shared their knowledge and the latest advancements in prevention and treatment of asthma management in Vietnam at a recent symposium in Hanoi.

The symposium entitled 'Responding to World Asthma Day 2025', was jointly organised by the Vietnam Respiratory Society in collaboration with GSK Vietnam.

At the event, participants heard that asthma is a common chronic respiratory disease affecting over 300 million people worldwide. In Vietnam, the average asthma prevalence is about 3.9% of the population, equivalent to approximately four million people. Notably, this disease causes about 3,000 to 4,000 deaths each year.

Experts emphasised that asthma management and prevention still faces many challenges. Asthma is also an underlying condition that weakens the body's immune system and creates favourable conditions for viruses to attack, including influenza and the Varicella Zoster Virus, which causes shingles.

"Studies show that people with asthma have a 24% higher risk of developing shingles and over a 20% higher risk of post-herpetic neuralgia. Notably, asthma patients have a 90% higher risk of developing shingles in the eye compared to people without asthma,” said Dr Le Thi Thu Huong, Head of the Department of Respiratory Internal Medicine at Gia Dinh People Hospital in HCM City.

According to Dr Phan Thu Phương, Director of Respiratory Centre at Bạch Mai Hospital, asthma management requires a multifaceted approach beyond medication, with proactive control of the underlying condition playing a crucial role. This involves managing symptoms and modifiable risk factors, preventing infectious diseases, controlling comorbidities.

Dr Le Khac Bao, Deputy Director of the University of Medical Ho Chi Minh City, said that better control of asthma can be achieved through personalised treatment. This requires a comprehensive strategy that includes evaluating patient characteristics, monitoring adherence and providing education to raise awareness among both patients and healthcare providers.

In addition to treatment, preventive strategies play a crucial role in managing these diseases by reducing infection-related exacerbations and stabilising lung function.

Dr Ngo Quy Chau, President of the Vietnam Respiratory Society (VRS), added: "Effective asthma management is essential, as it helps control complications and reduce asthma-related deaths. The VRS highly values the collaborative efforts of all stakeholders in improving the asthma patients’ quality of life, contributing to a reduction in the burden on the healthcare system.”./.

VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.

PM Pham Minh Chinh (second from right) visits the Karolinska Institutet. (Photo: VNA)

PM seeks stronger medical ties with Sweden’s Karolinska Institutet

The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.

D.F (left), a US patient, at a follow-up examination with Do Lenh Hung, head of the department of urethral reconstructive surgery. (Photo: VNA)

High-quality healthcare services attract more foreign patients to Binh Dan Hospital

Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T

A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.

On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.